Literature DB >> 22674997

Naturally occurring swine influenza A virus PB1-F2 phenotypes that contribute to superinfection with Gram-positive respiratory pathogens.

Jenni N Weeks-Gorospe1, Heather R Hurtig, Amy R Iverson, Margaret J Schuneman, Richard J Webby, Jonathan A McCullers, Victor C Huber.   

Abstract

A combination of viral, bacterial, and host factors contributes to the severity and overall mortality associated with influenza virus-bacterium superinfections. To date, the virulence associated with the recently identified influenza virus protein PB1-F2 has been largely defined using models of primary influenza virus infection, with only limited assessment in models of Streptococcus pneumoniae superinfection. Specifically, these studies have incorporated isogenic viruses that differ in the PB1-F2 expressed, but there is still knowledge to be gained from evaluation of natural variants derived from a nonhuman host species (swine). Using this rationale, we developed the hypothesis that naturally occurring viruses expressing variants of genes, like the PB1-F2 gene, can be associated with the severity of secondary bacterial infections. To test this hypothesis, we selected viruses expressing variants in PB1-F2 and evaluated outcomes from superinfection with three distinct Gram-positive respiratory pathogens: Streptococcus pneumoniae, Staphylococcus aureus, and Streptococcus pyogenes. Our results demonstrate that the amino acid residues 62L, 66S, 75R, 79R, and 82L, previously proposed as molecular signatures of PB1-F2 virulence for influenza viruses in the setting of bacterial superinfection, are broadly associated with enhanced pathogenicity in swine in a bacterium-specific manner. Furthermore, truncated PB1-F2 proteins can preferentially increase mortality when associated with Streptococcus pyogenes superinfection. These findings support efforts to increase influenza virus surveillance to consider viral genotypes that could be used to predict increased severity of superinfections with specific Gram-positive respiratory pathogens.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22674997      PMCID: PMC3416121          DOI: 10.1128/JVI.00369-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  61 in total

Review 1.  Correlates of vaccine protection from influenza and its complications.

Authors:  Jonathan A McCullers; Victor C Huber
Journal:  Hum Vaccin Immunother       Date:  2012-01-01       Impact factor: 3.452

2.  Long-term evolution and transmission dynamics of swine influenza A virus.

Authors:  Dhanasekaran Vijaykrishna; Gavin J D Smith; Oliver G Pybus; Huachen Zhu; Samir Bhatt; Leo L M Poon; Steven Riley; Justin Bahl; Siu K Ma; Chung L Cheung; Ranawaka A P M Perera; Honglin Chen; Kennedy F Shortridge; Richard J Webby; Robert G Webster; Yi Guan; J S Malik Peiris
Journal:  Nature       Date:  2011-05-26       Impact factor: 49.962

3.  PB2 and hemagglutinin mutations are major determinants of host range and virulence in mouse-adapted influenza A virus.

Authors:  Jihui Ping; Samar K Dankar; Nicole E Forbes; Liya Keleta; Yan Zhou; Shaun Tyler; Earl G Brown
Journal:  J Virol       Date:  2010-08-11       Impact factor: 5.103

4.  Live attenuated influenza vaccine is safe and immunogenic in immunocompromised ferrets.

Authors:  Victor C Huber; Jonathan A McCullers
Journal:  J Infect Dis       Date:  2006-01-27       Impact factor: 5.226

5.  Severe methicillin-resistant Staphylococcus aureus community-acquired pneumonia associated with influenza--Louisiana and Georgia, December 2006-January 2007.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2007-04-13       Impact factor: 17.586

6.  Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae.

Authors:  Jonathan A McCullers; Kimberly C Bartmess
Journal:  J Infect Dis       Date:  2003-03-06       Impact factor: 5.226

7.  Association of 2009 pandemic influenza A (H1N1) infection and increased hospitalization with parapneumonic empyema in children in Utah.

Authors:  Krow Ampofo; Amy Herbener; Anne J Blaschke; Caroline Heyrend; Mark Poritz; Kent Korgenski; Robert Rolfs; Seema Jain; Maria da Glória Carvalho; Fabiana C Pimenta; Judy Daly; Edward O Mason; Carrie L Byington; Andrew T Pavia
Journal:  Pediatr Infect Dis J       Date:  2010-10       Impact factor: 2.129

8.  Reassortment of pandemic H1N1/2009 influenza A virus in swine.

Authors:  D Vijaykrishna; L L M Poon; H C Zhu; S K Ma; O T W Li; C L Cheung; G J D Smith; J S M Peiris; Y Guan
Journal:  Science       Date:  2010-06-18       Impact factor: 47.728

9.  Immunotherapy with a combination of intravenous immune globulin and p4 peptide rescues mice from postinfluenza pneumococcal pneumonia.

Authors:  Jenni N Weeks; Kelli L Boyd; Gowrisankar Rajam; Edwin W Ades; Jonathan A McCullers
Journal:  Antimicrob Agents Chemother       Date:  2011-03-07       Impact factor: 5.191

10.  Planning for an influenza pandemic: thinking beyond the virus.

Authors:  Jonathan A McCullers
Journal:  J Infect Dis       Date:  2008-10-01       Impact factor: 5.226

View more
  28 in total

Review 1.  Secondary bacterial infections in influenza virus infection pathogenesis.

Authors:  Amber M Smith; Jonathan A McCullers
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

Review 2.  The co-pathogenesis of influenza viruses with bacteria in the lung.

Authors:  Jonathan A McCullers
Journal:  Nat Rev Microbiol       Date:  2014-03-03       Impact factor: 60.633

3.  Emergence of Highly Pathogenic Avian Influenza A(H5N1) Virus PB1-F2 Variants and Their Virulence in BALB/c Mice.

Authors:  Ram P Kamal; Amrita Kumar; Charles T Davis; Wen-Pin Tzeng; Tung Nguyen; Ruben O Donis; Jacqueline M Katz; Ian A York
Journal:  J Virol       Date:  2015-03-18       Impact factor: 5.103

4.  Influenza A virus protein PB1-F2 impairs innate immunity by inducing mitophagy.

Authors:  Ruifang Wang; Yinxing Zhu; Chenwei Ren; Shuaike Yang; Shan Tian; Huanchun Chen; Meilin Jin; Hongbo Zhou
Journal:  Autophagy       Date:  2020-02-11       Impact factor: 16.016

5.  Contributions of Influenza Virus Hemagglutinin and Host Immune Responses Toward the Severity of Influenza Virus: Streptococcus pyogenes Superinfections.

Authors:  Joshua M Klonoski; Trevor Watson; Thomas E Bickett; Joshua M Svendsen; Tonia J Gau; Alexandra Britt; Jeff T Nelson; Evelyn H Schlenker; Michael S Chaussee; Agnieszka Rynda-Apple; Victor C Huber
Journal:  Viral Immunol       Date:  2018-06-05       Impact factor: 2.257

Review 6.  The role of influenza in the severity and transmission of respiratory bacterial disease.

Authors:  Michael J Mina; Keith P Klugman
Journal:  Lancet Respir Med       Date:  2014-08-15       Impact factor: 30.700

7.  A Novel Role for PDZ-Binding Motif of Influenza A Virus Nonstructural Protein 1 in Regulation of Host Susceptibility to Postinfluenza Bacterial Superinfections.

Authors:  Kelly Shepardson; Kyle Larson; Hanbyul Cho; Laura Logan Johns; Zeynep Malkoc; Kayla Stanek; Julia Wellhman; Sarah Zaiser; Jaelyn Daggs-Olson; Travis Moodie; Joshua M Klonoski; Victor C Huber; Agnieszka Rynda-Apple
Journal:  Viral Immunol       Date:  2019-03-01       Impact factor: 2.257

8.  Desialylation of airway epithelial cells during influenza virus infection enhances pneumococcal adhesion via galectin binding.

Authors:  Mihai Nita-Lazar; Aditi Banerjee; Chiguang Feng; Mohammed N Amin; Matthew B Frieman; Wilbur H Chen; Alan S Cross; Lai-Xi Wang; Gerardo R Vasta
Journal:  Mol Immunol       Date:  2015-01-16       Impact factor: 4.407

9.  Molecular signatures of virulence in the PB1-F2 proteins of H5N1 influenza viruses.

Authors:  Amber M Smith; Jonathan A McCullers
Journal:  Virus Res       Date:  2013-03-14       Impact factor: 3.303

10.  Seasonal H3N2 influenza A virus fails to enhance Staphylococcus aureus co-infection in a non-human primate respiratory tract infection model.

Authors:  Scott D Kobayashi; Randall J Olsen; Rachel A LaCasse; David Safronetz; Madiha Ashraf; Adeline R Porter; Kevin R Braughton; Friederike Feldmann; Dawn R Clifton; John C Kash; John R Bailey; Donald J Gardner; Michael Otto; Douglas L Brining; Barry N Kreiswirth; Jeffrey K Taubenberger; Michael J Parnell; Heinz Feldmann; James M Musser; Frank R DeLeo
Journal:  Virulence       Date:  2013-10-08       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.